You are here
Our Research > Drug Development
Drug Development
-
Design, chemical synthesis and evaluation of novel molecular structures as potential clinical drugs: for breast cancerand Burkitt’s Lymphoma
-
Azetidinone analogues of Combretastatin A-4 as tubulin targeting agents
- Selective Estrogen receptor modulators and tubulin-targeting drugs
-
Pro-drug optimisation of our current candidates
Synthesis and biochemistry of ER and tubulin antagonists
-
Dual ER/aromatase and tubulin/aromatase targeting products
- Dual acting HSP 90 / tubulin targeting products
-
Design of Multidrug resistance/P-glycoprotein modulators
-
Natural Product Drug Discovery
-
Anti-cancer lead discovery from Ethno-medicine (Sub-Saharan Africa, India and Pakistan) and evidence-based traditional Chinese medicine
-
Anti-cancer lead discovery from natural sources (Marine, Terrestrial plants, fungi and microorganisms)
Cross-hybridisation of naturally occurring molecules to form novel anti-cancer scaffolds
Pharmacy Professors Associated with Disease, Drug Mechanisms & Safety
